US Patent 8039009 | US Patents | Expiry | Expiration | Dates

01

ABBVIE

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-24

MEMANTINE HYDROCHLORIDE

US Patent Number : 8039009

Drug Substance Claim :

Drug Product Claim :

Application Number : 22525

Patent Use Code : U-539

Patent Use Description : TREATMENT OF MODERATE ...

Patent Expiration Date : 2029-03-24

Product Web Link

Corporate PDF

02

ABBVIE

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-24

MEMANTINE HYDROCHLORIDE

US Patent Number : 8039009

Drug Substance Claim :

Drug Product Claim :

Application Number : 22525

Patent Use Code : U-539

Patent Use Description : TREATMENT OF MODERATE ...

Patent Expiration Date : 2029-03-24

Product Web Link

Corporate PDF

03

ABBVIE

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-24

MEMANTINE HYDROCHLORIDE

US Patent Number : 8039009

Drug Substance Claim :

Drug Product Claim :

Application Number : 22525

Patent Use Code : U-539

Patent Use Description : TREATMENT OF MODERATE ...

Patent Expiration Date : 2029-03-24

Product Web Link

Corporate PDF

04

ABBVIE

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-24

MEMANTINE HYDROCHLORIDE

US Patent Number : 8039009

Drug Substance Claim :

Drug Product Claim :

Application Number : 22525

Patent Use Code : U-539

Patent Use Description : TREATMENT OF MODERATE ...

Patent Expiration Date : 2029-03-24

Product Web Link

Corporate PDF

05

ABBVIE

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-24

DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE

US Patent Number : 8039009

Drug Substance Claim :

Drug Product Claim :

Application Number : 206439

Patent Use Code : U-1641

Patent Use Description : MEMANTINE HCL/DONEPEZI...

Patent Expiration Date : 2029-03-24

Product Web Link

Corporate PDF

06

ABBVIE

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-24

DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE

US Patent Number : 8039009

Drug Substance Claim :

Drug Product Claim :

Application Number : 206439

Patent Use Code : U-1641

Patent Use Description : MEMANTINE HCL/DONEPEZI...

Patent Expiration Date : 2029-03-24

Product Web Link

Corporate PDF

07

ABBVIE

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-24

DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE

US Patent Number : 8039009

Drug Substance Claim :

Drug Product Claim :

Application Number : 206439

Patent Use Code : U-1641

Patent Use Description : MEMANTINE HCL/DONEPEZI...

Patent Expiration Date : 2029-03-24

Product Web Link

Corporate PDF

08

ABBVIE

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-24

DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE

US Patent Number : 8039009

Drug Substance Claim :

Drug Product Claim :

Application Number : 206439

Patent Use Code : U-1641

Patent Use Description : MEMANTINE HCL/DONEPEZI...

Patent Expiration Date : 2029-03-24

Product Web Link

Corporate PDF

AbbVie Inc

VISIT THE VIRTUAL BOOTH

Review portfolio & marketing content

CONTACT DETAILS

Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

PRESENTATION(s)

DIGITAL CONTENT

1 CORPORATE CONTENT #SupplierSpotlight

12 DATA COMPILATION #PharmaFlow

2653 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

DEVELOPMENTS

306 Drugs in Development

FINISHED DOSAGE FORMULATIONS

INSPECTIONS & REGISTRATIONS

Filters

01

02

03

04

05

06

07

08